Search

FDA takes another look at CBD, but insiders are skeptical much will change U.S. health regulators are taking their closest look in more than three years at the idea of incorporating cannabinoids into dietary supplements. But hopes are dim that Tuesday’s daylong review by the U.S. Food and Drug...

ATHLETICS RISK MANAGEMENT Saul Ewing attorneys Amy Piccola, Andrea Brockway and Tricia Duffy, along with Sam Swartout of United Educators, will speak at the University & College Insurance Consortium (UCIC) 11th Annual Safety Leadership Conference on June 14th on the topic of Athletics Risk...

Jonathan Havens, co-chair of the Firm's Cannabis Law Practice and Food, Beverage and Agribusiness Practice, will speak at the Food and Drug Law Institute’s Annual Conference as a panelist during the session on “Preparing for Federal Legalization of Cannabis: Lessons Learned from Other Industries.”...

To Correct, or to Let Stand? When high-profile figures lie about their academic records, the institutions they attended must perform a delicate balancing act between protecting their privacy and telling the truth. by Liam Knox “The hands of the institution are tied in a lot of ways from getting...

Zachary Kobrin spoke on a panel titled, “A comparison of State Models” at the 6th Annual Canna Business & Wellness Conference and Expo, presented by the Cannabis Law, Accounting & Business (Cannabis LAB). The conference focused on the critical issues and challenges impacting the entire industry.

In just two months, from mid-November 2020 to mid-January 2021, Saul Ewing LLP's Cannabis Law Practice assisted clients in closing transactions with a combined deal value of more than $520 million. We served as: U.S. counsel to Canaccord Genuity Corp., lead underwriter of an overnight marketed...